Clinical trial
Capecitabine Plus Radiotherapy for Local Relapse Breast Cancer With Negative…
NCT00434941 · Spanish Breast Cancer Research Group, Other · Terminated
Key facts
| NCT number | NCT00434941 |
|---|---|
| Title | Capecitabine Plus Radiotherapy for Local Relapse Breast Cancer With Negative Her2 Tumours |
| Official title | Multicenter Phase IV.II Trial, for the Administration of Capecitabine Simultaneous to Radiotherapy for Local Relapse Breast Cancer Patients With Negative Her2 Tumours |
| Lead sponsor | Spanish Breast Cancer Research Group, Other |
| Collaborators | Hoffmann-La Roche Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug, Radiation |
| Interventions | Capecitabine, Radiotherapy |
| Enrollment | 1 |
| Start date | Sep 1, 2007 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | Feb 14, 2007 |
| Last update posted | Feb 21, 2019 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: